5 The same SPI is used for the weight management indication (Figure 1)
Robust clinical trial data demonstrate that tirzepatide produces significant reductions in total body weight, with evidence suggesting preferential loss of fat mass, including visceral (abdominal) fat
Inflammatory and oxidative stress markers in skeletal muscle of obese subjects
Suchitra MM, Ashalatha VL, Sailaja E, Rao AM, Reddy VS, Bitla AR, et al
Death from cardiovascular causes or a worsening heart-failure event occurred in 9.9% of the tirzepatide group versus 15.3% of the placebo group
Related Reading Remedy Meds Cost Lifemd Cost Mochi Price Ivim Price Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims